Amarantus Bioscience Holdings Inc (AMBS)

[brharris]

From the conf call:

Now as far as the business development update for LymPro, we made significant progress in the last several weeks. We’re under NDA with a number of parties, a number of parties are conducting due diligence on the data that we generated at ICON and are beginning now that the data -- we have the data under confidentiality are beginning to conduct due diligence on the LP-002 study and we’re hopeful to be able to make additional announcements regarding development from the business development area, in and around and following the AAIC meeting. I can’t say anything further beyond that but we’re very pleased with how the business development activity for LymPro is currently going.

Sure sounds like someone is interested in Lympro.